SIGN UPLog In
Cerephex
Cerephex
Company

Last deal

$5.9M

Amount

Series A

Stage

12.10.2012

Date

1

all rounds

$5.9M

Total amount

General

About Company
Cerephex develops diagnostic and therapeutic technologies for chronic central pain.

Industry

Sector :

Subsector :

Keywords :

Also Known As

NewNeuro, Great Lakes BioScoience

founded date

01.01.2012

Number of employees

51-100

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company is focused on developing its proprietary RINCE technology for noninvasive brain stimulation. Their NeuroPoint device, built upon the RINCE signal technology platform, is being developed for the management of fibromyalgia. Cerephex aims to gain FDA approval for the NeuroPoint device, which will be used in existing clinical outpatient offices under physician supervision.
Contacts

location

Mountain View, CA, USA

Phone number

Website URL

http://www.cerephex.com/

Social url